The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles

Cao, J (Cao, Jing)^[ 1 ] ; Zhang, YH (Zhang, Yahui)^[ 1 ] ; Wu, YK (Wu, Yukun)^[ 1 ] ; Wu, J (Wu, Jing)^[ 1 ] ; Wang, W (Wang, Wei)^[ 1 ] ; Wu, Q (Wu, Qiang)^[ 1 ] ; Yuan, Z (Yuan, Zhi)^[ 1,2 ]

COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 161: 508-518

DOI: 10.1016/j.colsurfb.2017.11.015

  WOS:000423636100060

Abstact

It has been shown that multivalent ligands could significantly enhance the binding avidity compared with the monovalent ones; therefore, once incorporated into nanoparticles, they promote superior targeting ability without increasing the ligand density. Although ligand valency and density play a key role on the targeting ability of corresponding nanoparticles, these facotrs remain largely unexplored and detailed studies are lacking. Herein, a series of multivalent ligands with certain valencies (FA,,, n indicates the valency of ligand: n =3, 5, 7) has been conveniently synthesized by conjugating different copies of folate ligands with poly(acrylic acid) (PAA). Negatively charged chitosan nanoparticles (CTS-SA NPs) have been utilized as proper multivalent platforms because they can strongly suppress non-specific protein adsorption and cellular uptake without interfering with the targeting ability of multivalent ligands. Subsequently, the structure of CTS-SA NPs has been modified using different amounts of FA(n) to form multivalent nanoparticles (FA(n)-CTS-SA NPs) with various valencies and densities. A series of specific investigations of them suggested that the cellular uptake of multivalent nanoparticles has largely varied with the ligand valency variation even at similar ligand densities; and also largely varied with ligand density variation even at the same ligand valencies. The intermediate valency and density values determined in the current study (ie., 5 and 2.4 wt%, respectively) have provided the best cellular uptake, facilitating superior targeting ability at relatively low ligand valency and density. Unexpectedly, no conspicuous difference has been observed during endocytotic inhibition assays with single inhibitors, which may be attributed to the synergetic endocytotic mechanism with multiple pathways of multivalent nanoparticles. The optimal multivalent nanoparticles have also exhibited excellent biocompatibility, long-term stability in vitro and enhanced circulation time in vivo, thus demonstrating their potential for targeted drug delivery. (C) 2017 Elsevier B.V. All rights reserved.